Viatris (VTRS) Cash from Operations (2019 - 2026)

Viatris' (VTRS) quarterly Cash from Operations came in at 388300000.0 in Q1 2026, down 27.49% year-on-year from 535500000.0 in Q1 2025, and down 52.4% quarter-over-quarter from 815800000.0 in Q4 2025.

Viatris (VTRS) Cash from Operations (2019 - 2026) Analysis & Trends

Viatris' Cash from Operations history runs 8 years deep, the most recent figure standing at 388300000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 27.49% year-over-year to 388300000.0 in Q1 2026; TTM through Mar 2026 was 2168700000.0, a 2.48% decrease from a year earlier, with the FY2025 full-year figure at 2315900000.0, up 0.56% from the prior year.
  • Cash from Operations declined to 388300000.0 in Q1 2026 per VTRS's latest filing, from 815800000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1138500000.0 in Q1 2022 and bottomed at 189000000.0 in Q4 2022.
  • The 5-year median for Cash from Operations is 614600000.0 (2024), against an average of 641535294.12.
  • Across the five-year window, Cash from Operations sank 63.87% in 2022 and surged 200.79% in 2023, its largest moves.
  • Year by year, Cash from Operations stood at 189000000.0 in 2022, then jumped by 200.79% to 568500000.0 in 2023, then declined by 15.09% to 482700000.0 in 2024, then soared by 69.01% to 815800000.0 in 2025, then slumped by 52.4% to 388300000.0 in 2026.
  • Per Business Quant, the three latest VTRS Cash from Operations figures stand at 388300000.0 (Q1 2026), 815800000.0 (Q4 2025), and 744900000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 11.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 388.30 Mn
Mar 31, 2026 388.30 Mn
Dec 31, 2025 815.80 Mn
Dec 31, 2025 815.80 Mn
Sep 30, 2025 744.90 Mn
Sep 30, 2025 744.90 Mn
Jun 30, 2025 219.70 Mn
Jun 30, 2025 219.70 Mn
Mar 31, 2025 535.50 Mn
Mar 31, 2025 535.50 Mn
Dec 31, 2024 482.70 Mn
Dec 31, 2024 482.70 Mn
Sep 30, 2024 826.50 Mn
Sep 30, 2024 826.50 Mn
Jun 30, 2024 379.10 Mn
Jun 30, 2024 379.10 Mn
Mar 31, 2024 614.60 Mn
Mar 31, 2024 614.60 Mn
Dec 31, 2023 568.50 Mn
Dec 31, 2023 568.50 Mn